Back to Search
DAVID SCHWARTZ, PHD
PHD
Psychologist
NPI: 1427102193Individual
Specialties, Licenses & Credentials
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.
PMID 19372568·Mol Cancer Ther·2009
7-preclinical
Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.
PMID 19095376·Int J Radiat Oncol Biol Phys·2009
8-other
Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
PMID 18213725·Head Neck·2008
8-other
Restless legs syndrome (RLS) in anemic patients with congestive heart failure and chronic renal failure: lack of effect of anemia treatment.
PMID 19131126·Int J Cardiol·2010
3-trial
Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity.
PMID 19637336·Inflamm Bowel Dis·2010
4-observational
A 31-year-old patient with colitis and perianal disease.
PMID 19615469·Clin Gastroenterol Hepatol·2010
5-case
Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohn's disease.
PMID 19637325·Inflamm Bowel Dis·2010
8-other
Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.
PMID 19679406·Int J Radiat Oncol Biol Phys·2010
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6621 FANNIN ST, CCC 1630.00
HOUSTON, TX 77030 - Phone
- (832) 822-3700
Quick Facts
- NPI
- 1427102193
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile